However, more long-term, controlled studies are needed to establish the safety of the proposed therapy
TRULICITY dulaglutide injection, solution
PMC For laboratory and research use only
doi: 10.3389/fendo.2025.1483199 Received 19 August 2024 Accepted 10 January 2025 Published 17 February 2025 Volume 16 - 2025 Edited by Brenda Kohn, New York University, United States Reviewed by Ekaterina Koledova, Merck, Germany Torben Laursen, Aarhus University Hospital, Denmark Updates Copyright 2025 Levshtein, Sharkia, Shimshi-Barash, Almagor, Albertsson-Wikland, Hochberg, Pillar and German
Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice
Good middle-ground option between CagriSema and cag + reta